A randomised double-blind controlled trial of BCNU as second-line therapy in metastatic oesophago-gastric, colorectal and pancreatic cancer

Update Il y a 4 ans
Reference: ISRCTN58648476

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Not provided at time of registration


Inclusion criteria

  • Colon, Oesophagus, Pancreas, Rectum, Stomach cancers

Links